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chologist conducted semi-structured individual interviews with 2 clinical experts 
and 30 patients in the UK recruited through general practitioners. Clinical experts 
were asked to identify key concepts attributable to the overactive bladder (symp-
toms). Patients were asked to describe their symptoms and impact on HRQL and 
rate them. All patient responses were coded using code frequency and bother rat-
ings. Results: Seven men, 23 women were interviewed; the majority of patients 
were older than 65 years. 50% of the patients were incontinent. Preliminary analysis 
suggests that OAB affects the patient’s quality of life on several aspect of their 
life: psychological (embarrassment and worry), occupational limitations, domes-
tic (usual activities) and limitations in leisure activities. All patients reported that 
feeling the need to go ‘‘too often’’ to the bathroom (urgency and frequency) led to 
significant limitations such as avoidance of any unplanned activities. HRQL con-
cepts were similar across the different age group. As expected, patients suffering 
from urgency incontinence reported this symptom as being the most impactful, 
especially in terms of embarrassment and worry. ConClusions: Although the 
impact of all OAB symptoms was found to be significant and similar across all 
patients regardless of their age, the greatest impact or burden of OAB was felt and 
reported by wet patients compared to dry patients.
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objeCtives: Bladder cancer (BC) is the fourth most common malignancies among 
men and it has high medical costs per-patient from diagnosis until death. Generally 
little is known about the burden BC imposes on patients’ health-related quality 
of life (HRQL) and the literature lacks detailed utility data for economic evalua-
tions in BC. The authors’ goal was to assess the HRQL and health status utility of 
BC patients. Methods: A cross sectional survey was performed in three hospital 
based urology centres. Adult patients with BC attending routine care were invited to 
participate in the study. Data on demographics, disease history and co-morbidities 
were obtained, validated versions of the EQ-5D and SF-36 generic questionnaires 
were applied. The UK tarrifs were used to calculate EQ-5D score and the SF-36 was 
converted to SF-6D utilities. Disease-specific HRQL was assessed by the FACT-BL 
questionnaire. Results: Altogether 98 patients (males 63.3%) were involved with 
mean age of 66.4 (SD= 8.6) and disease duration of 3.4 (SD= 3.0) years. The SF-36 
physical and mental health summary measures were 62 (SD= 24), 65 (SD= 24), 
respectively, the scores of the 8 domains were comparable to the > 65 years old 
general population’s results. The average SF-6D, EQ-5D and EQ VAS utility scores 
were 0.705 (SD= 0.145), 0.772 (SD= 0.252) and 68.8 (SD= 19.0). The difference of EQ-5D 
score compared to the age-matched population norm was not significant (p= 0.65). 
The FACT-BL physical, social, emotional and functional well-being scores were 
mean 23.1 (SD= 5.4), 20.6 (SD= 5.7), 18.1 (SD= 5.1) and 19.0 (SD= 6.7), the total score 
was 114.0 (SD= 23.5). ConClusions: According to our knowledge this study is the 
first to assess BC patients’ HRQL using diverse preference based measures. Further 
studies involving larger samples might increase our knowledge on the performance 
of these questionnaires in BC subgroups by disease stage, type of treatment and 
urinary diversion.
PUK32
tHe BURden of UntReated Patients exPeRienCing symPtoms of 
oveRaCtive BladdeR
Pedersini R.1, Isherwood G.2, Vietri J.3
1Kantar Health, Epsom, UK, 2Kantar Health, Epsom, Surrey, UK, 3Kantar Health, Milan, Italy
objeCtives: The reluctance of those with overactive bladder OAB to seek medical 
advice can leave a considerable part of the population untreated, with significant 
costs for society. The present study investigates the burden of individuals who 
experience symptoms of OAB but are not treated. Methods: Data were taken 
from the 5EU (France, Germany, Italy, Spain, and UK) 2013 National Health and 
Wellness Survey (NHWS), a cross-sectional survey representative of the total adult 
populations in each 5EU market. 62,000 respondents self-reported physician diag-
nosis of various health conditions, including 1,347 who reported symptoms com-
patible with OAB. These respondents were compared to those who didn’t report 
symptoms of OAB. Variables of interest were demographics (age, gender, marital 
status, education, income and employment status), BMI, alcohol and smoke behav-
iour, health-related quality of life (HR-QoL), work productivity and activity impair-
ment (WPAI). Results: The OAB group, compared to the controls, was older (57 
vs. 47 years), with a lower education level (49.14% went to college vs. 54.49%), less 
were in a relationship (26.43% vs. 31.82%), less were employed (35.04% vs. 58.15%), 
more were obese (31.11% vs. 17.22%), they had lower HR-QoL (SF-36v2, PCS: 42.09 
vs. 51.36; MCS: 42.55 vs. 46.25; Utility: 0.62 vs. 0.73), had lower work productivity 
(overall work impairment of 34.46 vs. 20.03) and higher activity impairment (46.07 
vs. 24.35). All differences were significant (p< 0.001). ConClusions: Respondents 
reporting symptoms compatible with OAB but are not treated and would not be 
captured by clinical studies, are significantly worse-off than the rest of the popu-
lation, e.g. in their quality of life, income and work productivity. It is likely that 
undergoing treatment would benefit them and decrease health care costs.
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patients completed the SNM pre-implant evaluation; data from 265 subjects were 
included in EQ-5D or EIQ analyses. Matched paired t-tests compared EQ-5D scores 
and costs from baseline to each follow-up. Results: Baseline mean EQ-5D index 
score (n= 265) was 0.777. Index scores significantly improved (p< 0.05) from base-
line at each follow-up period [3-months (n= 247)= 0.850, 6-months (n= 246)= 0.828, 
and 12-months (n= 232)= 0.839]; the largest improvement in scores (0.073) was at 
3 months. The proportion of patients reporting no problems on the EQ-5D dimen-
sions of Usual Activities, Anxiety/Depression and Pain/Discomfort and Self-Care 
increased from 61.2% (baseline) to 72.0% (12 months); 57.3% to 69.4%; 40.9% to 50.9%, 
and 93.1% to 95.3%, respectively; the Mobility dimension had a non-significant 
decline (68.5% to 66.4%). At baseline, study subjects reported a 3-month average 
expenditure of $228 (US) for durable and disposable medical supplies and health 
service utilization; 74% of the expenditure was attributed to ER, hospitalization and 
outpatient health services use. Expenditures significantly declined (p< 0.05) by an 
average of $163 per 3-month period post-implant. ConClusions: After receiving 
SNM implant, EQ-5D index scores were significantly improved and self-reported 
durable and disposable medical supplies and health service expenses to manage 
OAB were significantly reduced.
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objeCtives: 1) To determine what is the utility change for kidney donors from 
before to 3 months after donation; 2) To determine the minimal important differ-
ence (MID) of a decrease (MIDe) in utility for kidney donors. Methods: We used 
data from a prospective multicenter observational study, measuring the Health 
Related Quality of Life (HRQoL) of kidney donors before and three months after 
transplantation. Utility scores were estimated using the SF-6D and EQ5D. Two 
methods were used to estimate the MIDe: i) the anchor-based method by the 
Global Rating of Change (GRoC) for donors rating their global health “somewhat 
worse” 3 months after donation; ii) the distribution-based method by the standard 
error of measurement (SEM). Results: In total, 211 donors for the EQ-5D and 192 
for the SF-6D completed the questionnaire. Results showed a significant (p< .0001) 
decrease in utility score at three months. The mean (SD) utility score before trans-
plantation was 0.932 (±0.091) with the EQ5D, and 0.834 (±0.085) using the SF-6D, 
and 0.882 (±0.151) and 0.757 (±0.118) respectively at three months with a significant 
decrease (< .0001). Half of donors (53.9%) rated their global health “about the same” 
and 35 (15.4%) “somewhat worse” at follow up. Using the GRoC method, the MIDe 
was -0.113 units for the EQ-5D and -0.128 units for the SF-6D. By the SEM method, 
MIDe was -0.076 for the EQ5D and -0.073 for the SF6D. More than third of patient 
rechead the MIDe using the SEM method. ConClusions: This study showed a 
significant descrease in utility score three months after donation in most donors 
while reporting their global health “about the same”. The MIDe can be used by 
clinician as a threshold to identify donors with a meaningful decrease in utility 
score in a short run after donation.
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objeCtives: Urinary incontinence (UI) is a public health issue with a considerable 
social and economic impact. It affects temporarily or permanently about 400 000-500 
000 adults in Hungary. The purpose of our study was to estimate the prevalence, 
consultation rates and treatment behaviour of the adult population. Methods: 
In 2012 a 15-item questionnaire survey was performed as a part of a mobile 
health unit screening “The comprehensive health test program of Hungary 2010-
2020”. Results: Altogether 13 355 respondents (60.4% female) completed the ques-
tionnaire, the mean age was 40.2 years (SD 12.2). The prevalence rate of UI was 9.7% 
(n= 786) of women and 3.8% (n= 200) of men. Consultation rates were 22.9% (n= 180) 
for women and 32.5% (n= 65) for men. Seventy-three women (40.6%) consulted a 
gynaecologist, 37 (20.5%) a GP, 46 (25.6%) an urologist and 24 (13.3%) consulted more 
than one physicians. Five men (7.7%) consulted a GP, 44 (67.7%) an urologist and 
16 (24.6%) didn’t answer. Among those who consulted a physician 52.2% (n= 94) of 
women and 66.2% (n= 43) of men found solution for their urinary symptoms. In the 
group of respondents who consulted a doctor (n= 245) the most common therapies 
were medications, surgical treatment, absorbent pads or any combination of the 
foregoing. In the group who self-managed their symptoms without consulting a 
doctor (n= 741) absorbent products and/or pelvic muscle training were the most 
frequently applied therapies. ConClusions: Our prevalence results are in line 
with the international UI screenings. We found low medical consulting rates and 
the majority of the respondents having symptoms used self-management tech-
niques for UI.
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objeCtives: To review and identify HRQL dimensions in dry and wet OAB patients 
through literature review and patient interviews. Methods: A literature review 
on OAB HRQL was performed using the EMBASE database. Specialized forums were 
also searched for relevant HRQL issues reported by OAB patients. A trained psy-
A636  VA L U E  I N  H E A LT H  1 6  ( 2 0 1 3 )  A 3 2 3 – A 6 3 6  
annual reduction in the number of ESA administrations following conversion to 
C.E.R.A. was 77 (21-138). Average time per patient HD session was 1.54 minutes for 
ESA (95% CI: 1.17-1.90) vs. 1.64 minutes for C.E.R.A. (95% CI: 1.57-2.02). Estimated 
time/patient/year was 137 min (range: 65-277) for ESA and 20 min for C.E.R.A. (range: 
5-51). Assuming a 100% uptake of Q4W C.E.R.A. maintenance therapy, annual time 
savings/centre for frequent anaemia management tasks would be 86% (range: 
62-95%). ConClusions: Substantial annual time savings on frequent anaemia 
management-related tasks were found in HD centres in Italy with 100% uptake of 
Q4W C.E.R.A. maintenance therapy.
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objeCtives: The surgical management of vesicoureteral reflux consists of open 
and minimally invasive approaches. Open approaches are associated with post-
operative hospitalization rates of stay typically 2 to 3 days, varying with the type 
of procedure. We evaluated the impact of a “one night cost-saving stay process of 
care” model for open surgical correction of vesicoureteral reflux on quality of care, 
as defined by return to emergency room or office and/or readmission to the hospital 
within 2 days of discharge. Methods: An IRB-approved chart review of all open 
uncomplicated ureteral reimplantations for vesicoureteral reflux from the January 
2009 through January 2013 was performed. Length of postoperative stay, emergency 
room records, hospitalizations and office records were reviewed to assess for pres-
entation to the emergency room/office and/or readmission to the hospital within 2 
days of discharge from the ureteral reimplantation. Results: Ninety-five children 
(17 males, 78 females) underwent open ureteral reimplantation. Eighty-four (88.4%) 
were discharged POD #1 , 8 (8.4%) on POD #2 and 3 (3.2%) on the POD #3. Two patients 
presented to the ER within 2 days of discharge, one in the one night stay group and 
one in the three night stay group. No child required readmission within 2 days of 
discharge. Transient ureteral obstruction requiring stent placement occurred in 1 
patient (1.05%) 3 days after discharge. Presentation to the ER > 2 days post-discharge 
was more frequent in those discharged from home POD #1. ConCl usions: A pro-
cess of care model decreased the length of stay to one night in 84 of the 95 patients 
(88.4%) and did not appear to increase the risk of early (within 2 days of discharge) 
presentation to the ER/office or readmission. ER/office presentations > 2 days after 
discharge were increased in the POD #1 group.
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objeCtives: To assess resource use and costs in the usual clinical management of 
pregnant obese women, considered at high risk for developing GDM. Methods: 
Information was collected in the framework of the DALI project by means of a 
structured survey about usual clinical practice in the management of obese women 
from week 12 of pregnancy until delivery and a second survey about unit costs of 
related tests and interventions including analytics, imaging tests, follow-up visits 
and delivery. 9 centers in 8 EU countries were included (Austria, Belgium, Denmark, 
Ireland, Italy, The Netherlands, Spain, UK) Unit costs were inflated, using consumer 
price index when needed to 2012 prices and exchanged to US$ using power purchase
parities. Results: According to the reported data, resource utilization according 
to usual practice in management of obese women differed across countries: num-
ber of ultrasound scans ranged 2-6, OGTT 0-3, obstetrician visits 2-10, GP visits 
0-6, nurse/midwife visits 0-12. Follow-up involved different professionals depend-
ing on the country (GPs, obstetricians, nurses, midwives, diabetes educators and 
endocrinologists). Mean costs were 4,624 US$ (SD 2,034), ranging from 2,571 US$ in 
Belgium to 7,682 US$ in Denmark. The main drivers for costs were delivery, health 
care professionals’ follow-up visits and ultrasound scans. When delivery costs were 
excluded mean costs dropped to 722 US$ (SD 226), ranging from 340 US$ in the UK 
to 1052 US$ in Spain. ConCl usions: A high heterogeneity in the management 
of obese women during pregnancy and in the unitary costs reported, are observed 
among the centers included in the study, associated with a threefold difference in 
costs across hospitals.
objeCtives: To identify and analyze the sensitivity pattern of microorganisms 
isolated and to study the antibiotic utilization pattern in complicated urinary tract 
infection (cUTI) and the outcome of the therapy. Methods: Retrospective, observa-
tional study conducted in the medicine units of a tertiary care teaching hospital from 
January 2011 to December 2011. Patients who met the inclusion criteria were include 
in the study and patient details like demography, clinical diagnosis, microbiological 
data, antibiotic regimen used and patient outcome were recorded from the medical 
records. Data were analyzed using SPSS 20.0 Results: Out of 297 patients included 
in the study, majority of them were in the age group of 48-59 years. ESBL E. coli 
(61.4%) was the most common causative microorganism isolated, followed by E.coli 
(23.9%). The antibiotic sensitivity profile of microorganisms causing cUTI showed that 
E coli was sensitive to majority of the antibiotics and ESBL producing E. coli was most 
sensitive to cefoperazone-sulbactum followed by amikacin and carbapenems. Dual 
drug regimen was the most preferred choice for the treatment of cUTI compared to 
single or triple or more drug regimens. Among the different category of antibiotics 
used, cephalosporins was the most commonly prescribed while macrolides were the 
least preferred antibiotics. ConClusions: The treatment of ESBL E. coli with dual 
drug regimen showed maximum improvement in outcome (97.2%) followed by single 
drug regimen (89.7%). The organisms isolated were found to be more sensitive to 
cephalosporins, amikacin and carbapenems. Cephalosporins were the most effective 
antibiotic for the treatment of cUTI. The broader outcome of this study would be the 
potential utility of this data in designing strategies both at the level of physicians and 
the administrators for rational prescribing and policy decisions respectively.
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objeCtives: To determine the importance of long and short interdialytic 
interval leading to hospital readmission and mortality in hemodialysis 
patients. Methods: Reviewed data of 240 patients with 182 male and 58 female 
patients receiving maintenance hemodialysis (HD) twice weekly on a Mon/Thu, 
Tue/Fri, Wed/Sat schedule with prevalent adult’s HD patients on period from 2010 
through2012. Eligible patients were actively recruited who were on chronic HD 
fulfilling the inclusion criteria. Analyzed the patients getting frequent hospitalized 
for Infectious and cardiovascular (CV) admissions were determined by principal 
ICD-9-CM diagnosis codes. Results: A total of 240 patients with End-stage renal 
disease (ESRD) on long term hemodialysis were included the study cohort. The 
mean age was 50.4±13.6 years; 24.2% were women with a mean year of patients 
on hemodialysis of 4.2±2.6. Hypertension was the leading cause of end-stage 
renal disease in 28.8% of the patients, 27.1% of patients with hypertension and 
diabetes, 12% with diabetes and rest were due to Glomerulonephritis, Interstitial 
nephritis, Cystic kidney disease. Over the study period, mortality was 39.6% (95) , 
Cardiac cause 19.2 (46) were high on the day after 3 day interdialytic interval (31 
death vs. 15), Vascular cause 2.5% (6), Infection 7.5% (18), other cause 10.4% (25) 
and readmission was more both on the day after long interdialytic interval and 
day after short interdialytic interval for IHD, stroke, infection. ConClusions: 
Interdialytic interval does not influence mortality and readmission rates for all 
cause cardiovascular and infectious causes.
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objeCtives: A major challenge for haemodialysis (HD) centres is to maximise effi-
ciency in care provision while maintaining high standards of care. Our objective was 
to document health care professional (HCP) time for renal anaemia management 
for both shorter-acting erythropoiesis-stimulating agents (ESA) and Mircera, a con-
tinuous erythropoiesis receptor activator (C.E.R.A.) once monthly (Q4W), and model 
time savings with the use of Q4W C.E.R.A. Methods: This descriptive multi-centre 
Time and Motion (T&M) study was conducted in 13 centres in Italy. The time spent 
on frequent anaemia management-related tasks (preparation, distribution, and 
injection) was recorded for both ESA and C.E.R.A. groups in each centre by trained 
observers. Time/patient/session was used to calculate time/patient/year, time/
centre/year and modelling of potential time savings of a 100% uptake of C.E.R.A. A 
Random intercept generalized linear mixed effect model assuming gamma distri-
bution with log link function to account for the centre clustering effect was fitted 
for each task separately. Results: In all centres, more than 80% of an average 
86 ESRD patients received ESA treatment. The average number of ESA injections/
patient/year, weighted by type of ESA, frequency and route of administration, was 
89 (range: 33-150). The average uptake of C.E.R.A. was 26% (range 11-41%). The mean 
